Moderna asked the Food and Drug Administration on Thursday to expand the use of its Covid-19 vaccine to children ages 6 months to 5 years.
The drugmaker’s request will now be considered by the FDA, which is expected to make a final decision in June.
The agency is expected to seek the advice of its advisory committee, the Vaccines and Related Biological Products Advisory Committee.
